Medicare Policy on Screening Colonoscopies, Propofol Use Finalized

Steven Morris

Mark Casner, MBA
PCC Treasurer
CEO, Aisthesis


The Centers for Medicare and Medicaid Services (CMS) recently announced the release of the 2015 physician fee schedule. For those of us deep in the “trenches” providing anesthesia services to the gastroenterology community and the many patients we collectively serve, this bit of good news is definitely welcome.

back to top Back to top

Issue Brief #8: Drug Shortages Impact Colorectal Cancer Screenings

Blue Ribbon

Over the past several years, drug shortages have become an increasingly severe problem for those working throughout the health care industry, as well as for patients who depend on pharmaceuticals every day. Drug shortages are not new, but now hospitals and physicians are having more difficulty finding adequate supplies of drugs to meet the needs of their patients. Some of the drugs that have seen supply problems are those used in colorectal cancer screenings. If we realize the mission of dramatically increasing screening rates among Americans, drug shortages could prove to become an even bigger issue than it is today.

Part of an ongoing series from Preventing Colorectal Cancer, this issue brief sheds light on the impact of drug shortages on colorectal cancer. Find out what you need to know!

back to top Back to top

Issue Brief #9: Sneak Preview!

Colorectal cancer is the second leading cause of cancer deaths in the United States. Thankfully, it is also one of the most treatable and curable cancers, if detected early. Unfortunately, a high percentage of late stage colorectal cancers are fatal, with the American Cancer Society citing a five year survival rate of Stage IV cancers as low as only 6%. While preventative screening colonoscopies can go a long way in helping to catch cancerous polyps early and save lives, new medical developments in the field of genetic testing can help take colorectal cancer prevention to a new level.

Part of an ongoing series from Preventing Colorectal Cancer, this issue brief discusses the positive impacts that genetic testing has on the diagnosis and treatment of colorectal cancer. To request a copy of the issue brief, please email info@preventingcolorectalcancer.org.

back to top Back to top

Young Adults Face Increasing Risk of Colon Cancer

A new study found that the incidence of colon cancer is rising among young adults ages 20-34. It appears that lifestyle and diet habits, including obesity and lack of physical activity among young adults may be a factor. Find out more about this alarming trend.

back to top Back to top

In the News

  • IBD Patients Benefit from Colorectal Cancer Screenings
  • A High-Quality Colonoscopy Requires Preparation
  • New Genetic Tests Screen for Risk of Developing Cancer
  • Five Genes May Help Predict Colorectal Cancer Behavior

back to top Back to top

We Need Your Help!

Preventing Colorectal Cancer’s mission is to educate the public and key stakeholders about the opportunities to reduce the incidence of colorectal cancer by promoting optimal screening and therapeutic care for patients and clinicians.

We want you to join us and embrace the mindset that together we can make a difference in redefining the standard of care, campaigning for transparency in reimbursement methodologies, and fighting for the coverage of sedation during colonoscopies.

For more information, email info@preventingcolorectalcancer.org.